News Detail
![](pdf/Biogenetic_Drugs150524165449.jpg)
Solan, 15 May 2024: The working of the Drug Control Administration (DCA), Baddi, has come under the scanner as despite large-scale sale of psychotropic drugs in the last one year, the management of Biogenetic Drugs Private Limited failed to disclose details of the buyers to the a......
View Details
Source : The Tribune
Drug Control Administration (DCA) Baddi
Biogenetic Drugs Private Limited
psychotropic drugs
Special Task Force
alprazolam 0.5 tablets
Related News
- Centre issues licences to 3,200 MedTech units; grants 10,000 import licences (26-07-2024)
- Maha FDA Seizes Rs 1.41 Crore Worth of Unlicensed Ayurvedic Drugs (26-07-2024)
- 424 drugs have been declared spurious/adulterated during 2022-23: Govt in LS (26-07-2024)
- ICMR releases 32 new treatment standards for treating common and serious diseases (26-07-2024)
- Indian national charged with selling counterfeit cancer drugs (26-07-2024)
- US FDA finds data integrity, sterility problems at Brassica Pharma (26-07-2024)
- DCA Raids Shops Selling Habit-Forming Drugs (25-07-2024)
- BIS Sanctioned 82 Medical Device projects to develop standards (25-07-2024)
- Anti-Narcotics Task Force will be formed soon in Rajasthan: HM (25-07-2024)
- ICMR to strengthen IPR unit to safeguard and commercialize scientific innovations (25-07-2024)